{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:53:11Z","timestamp":1789386791494,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/bjc.2015.8","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T20:55:31Z","timestamp":1422996931000},"page":"809-818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase"],"prefix":"10.1038","volume":"112","author":[{"given":"D","family":"Di Gioia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Stieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G P","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Baur-Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"BFbjc20158_CR1","unstructured":"WHO (1979) WHO handbook for reporting results of cancer treatment. Geneva (Switzerland): World Health Organization Offset Publication No. 48."},{"issue":"20","key":"BFbjc20158_CR2","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1001\/jama.1994.03510440047031","volume":"271","author":"P Ghezzi","year":"1994","unstructured":"Ghezzi P, Magnanini S, Rinaldini M, Berardi F, Di Biagio G, Testare F, Tavoni N, Schittulli F, D\u2019Amico C, Pedicini T, Fumagalli M, Gritti G, Braga M, Marini G, Zaniboni A, Cosentino D, Epifani C, Gini G, Perroni D, Peradotto D, Indelli M, Santini A, Isa L, Aitini E, Cavazzini G, Smerieri F, Nascimben O, Busolin R, Papaccio G, Locatelli E, Monti M, Ghislandi E, Gottardi O, Majno M, Pluchinotta A, Armaroli L, Confalonieri C, Viola P, Galletto L, Sussio M, Trolli B, Biasio M, Rolfo A, Vaudano G, Giolito MR, Ambrosini G, Busana L, Molteni M, Richetti A, Marubini E, Piffanelli A, Salvadori B, Tognoni G, Zola P, Liberati A, Fossati R, Meyerowitz BE, Torri V, Apolone G, Mosconi P, Marsoni S, Liberati MC, Alexanian A, Grilli R, Nicolucci A, Monferroni N (1994) Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. JAMA 271 (20): 1587\u20131592.","journal-title":"JAMA"},{"issue":"16","key":"BFbjc20158_CR3","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1200\/JCO.2004.08.095","volume":"22","author":"F Andre","year":"2004","unstructured":"Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, Kabbaj O, Spano JP, Marsiglia H, Rouzier R, Delaloge S, Spielmann M (2004) Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 22 (16): 3302\u20133308.","journal-title":"J Clin Oncol"},{"issue":"6","key":"BFbjc20158_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1109653","volume":"366","author":"J Baselga","year":"2012","unstructured":"Baselga J, Campone M, Piccart M, Burris HA 3rd, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN (2012a) Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med 366 (6): 520\u2013529.","journal-title":"N Engl J Med"},{"issue":"2","key":"BFbjc20158_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa1113216","volume":"366","author":"J Baselga","year":"2012","unstructured":"Baselga J, Cortes J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM (2012b) Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 366 (2): 109\u2013119.","journal-title":"N Engl J Med"},{"issue":"2","key":"BFbjc20158_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/tbj.12070","volume":"19","author":"AS Berghoff","year":"2013","unstructured":"Berghoff AS, Bago-Horvath Z, Dubsky P, Rudas M, Pluschnig U, Wiltschke C, Gnant M, Steger GG, Zielinski CC, Bartsch R (2013) Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer. Breast J 19 (2): 149\u2013155.","journal-title":"Breast J"},{"issue":"1","key":"BFbjc20158_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","volume":"37","author":"R Boellaard","year":"2010","unstructured":"Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J, Hoekstra OS, Pruim J, Marsden PK, Tatsch K, Hoekstra CJ, Visser EP, Arends B, Verzijlbergen FJ, Zijlstra JM, Comans EF, Lammertsma AA, Paans AM, Willemsen AT, Beyer T, Bockisch A, Schaefer-Prokop C, Delbeke D, Baum RP, Chiti A, Krause BJ (2010) FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 37 (1): 181\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"BFbjc20158_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/annonc\/mdf101","volume":"13","author":"F Cardoso","year":"2002","unstructured":"Cardoso F, Di LA, Lohrisch C, Bernard C, Ferreira F, Piccart MJ (2002) Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Ann Oncol 13 (2): 197\u2013207.","journal-title":"Ann Oncol"},{"issue":"48","key":"BFbjc20158_CR9","first-page":"1597","volume":"49","author":"M Carlini","year":"2002","unstructured":"Carlini M, Lonardo MT, Carboni F, Petric M, Vitucci C, Santoro R, Lepiane P, Ettorre GM, Santoro E (2002) Liver metastases from breast cancer. Results of surgical resection. Hepatogastroenterology 49 (48): 1597\u20131601.","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"BFbjc20158_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1200\/JCO.1987.5.1.55","volume":"5","author":"GM Clark","year":"1987","unstructured":"Clark GM, Sledge GW Jr, Osborne CK, McGuire WL (1987) Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 5 (1): 55\u201361.","journal-title":"J Clin Oncol"},{"issue":"3","key":"BFbjc20158_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2214\/ajr.181.3.1810809","volume":"181","author":"IM Danet","year":"2003","unstructured":"Danet IM, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT, Kanematsu M (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181 (3): 809\u2013817.","journal-title":"AJR Am J Roentgenol"},{"issue":"30","key":"BFbjc20158_CR12","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1200\/JCO.2007.14.1168","volume":"26","author":"S Dawood","year":"2008","unstructured":"Dawood S, Broglio K, Gonzalez-Angulo AM, Buzdar AU, Hortobagyi GN, Giordano SH (2008) Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol 26 (30): 4891\u20134898.","journal-title":"J Clin Oncol"},{"issue":"2","key":"BFbjc20158_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ejrad.2008.10.031","volume":"73","author":"A Dirisamer","year":"2010","unstructured":"Dirisamer A, Halpern BS, Flory D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W (2010) Integrated contrast-enhanced diagnostic whole-body PET\/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer. Eur J Radiol 73 (2): 294\u2013299.","journal-title":"Eur J Radiol"},{"issue":"2","key":"BFbjc20158_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1148\/radiology.180.2.2068292","volume":"180","author":"RE Dorfman","year":"1991","unstructured":"Dorfman RE, Alpern MB, Gross BH, Sandler MA (1991) Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 180 (2): 319\u2013322.","journal-title":"Radiology"},{"issue":"9472","key":"BFbjc20158_CR15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"EBCTCG","year":"2005","unstructured":"EBCTCG EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (9472): 1687\u20131717.","journal-title":"Lancet"},{"issue":"1","key":"BFbjc20158_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00330-003-1968-7","volume":"14","author":"K Engelhard","year":"2004","unstructured":"Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA (2004) Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 14 (1): 99\u2013105.","journal-title":"Eur Radiol"},{"issue":"suppl","key":"BFbjc20158_CR17","doi-asserted-by":"crossref","first-page":"abstr e12015","DOI":"10.1200\/jco.2009.27.15_suppl.e12015","volume":"27","author":"I Ertl","year":"2009","unstructured":"Ertl I, Heinemann V, Laessig D, Nagel D, Seidel D, Stieber P (2009) CA 125 in the early detection of metastatic breast cancer. J Clin Oncol 27 (suppl): abstr e12015.","journal-title":"J Clin Oncol"},{"issue":"5","key":"BFbjc20158_CR18","first-page":"250","volume":"38","author":"HJ Gallowitsch","year":"2003","unstructured":"Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P (2003) F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol 38 (5): 250\u2013256.","journal-title":"Invest Radiol"},{"issue":"2","key":"BFbjc20158_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2214\/ajr.144.2.261","volume":"144","author":"GM Glazer","year":"1985","unstructured":"Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB (1985) Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 144 (2): 261\u2013265.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"BFbjc20158_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13 (1): 8\u201310.","journal-title":"J Clin Oncol"},{"issue":"3","key":"BFbjc20158_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12282-011-0267-4","volume":"19","author":"H Iwata","year":"2012","unstructured":"Iwata H (2012) Future treatment strategies for metastatic breast cancer: curable or incurable? Breast Cancer 19 (3): 200\u2013205.","journal-title":"Breast Cancer"},{"issue":"20","key":"BFbjc20158_CR22","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28 (20): 3271\u20133277.","journal-title":"J Clin Oncol"},{"issue":"7","key":"BFbjc20158_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","volume":"31","author":"JL Khatcheressian","year":"2013","unstructured":"Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ, Vogel VG, Wolff AC, Somerfield MR, Davidson NE (2013) Breast cancer follow-up and management after primary treatment: american society of clinical oncology clinical practice guideline update. J Clin Oncol 31 (7): 961\u2013965.","journal-title":"J Clin Oncol"},{"issue":"3","key":"BFbjc20158_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3349\/ymj.2014.55.3.558","volume":"55","author":"JY Kim","year":"2014","unstructured":"Kim JY, Park JS, Lee SA, Kim JK, Jeong J, Yoon DS, Lee HD (2014) Does liver resection provide long-term survival benefits for breast cancer patients with liver metastasis? A single hospital experience. Yonsei Med J 55 (3): 558\u2013562.","journal-title":"Yonsei Med J"},{"issue":"3","key":"BFbjc20158_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12282-012-0347-0","volume":"19","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Ichiba T, Sakuyama T, Arakawa Y, Nagasaki E, Aiba K, Nogi H, Kawase K, Takeyama H, Toriumi Y, Uchida K, Kobayashi M, Kanehira C, Suzuki M, Ando N, Natori K, Kuraishi Y (2012) Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review. Breast Cancer 19 (3): 218\u2013237.","journal-title":"Breast Cancer"},{"issue":"1","key":"BFbjc20158_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1148\/radiol.2331030777","volume":"233","author":"TC Lauenstein","year":"2004","unstructured":"Lauenstein TC, Goehde SC, Herborn CU, Goyen M, Oberhoff C, Debatin JF, Ruehm SG, Barkhausen J (2004) Whole-body MR imaging: evaluation of patients for metastases. Radiology 233 (1): 139\u2013148.","journal-title":"Radiology"},{"issue":"1","key":"BFbjc20158_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1148\/radiology.220.1.r01jl01145","volume":"220","author":"T Livraghi","year":"2001","unstructured":"Livraghi T, Goldberg SN, Solbiati L, Meloni F, Ierace T, Gazelle GS (2001) Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 220 (1): 145\u2013149.","journal-title":"Radiology"},{"issue":"2","key":"BFbjc20158_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1148\/radiol.2332030454","volume":"233","author":"MG Mack","year":"2004","unstructured":"Mack MG, Straub R, Eichler K, Sollner O, Lehnert T, Vogl TJ (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy\u2014local tumor control rate and survival data. Radiology 233 (2): 400\u2013409.","journal-title":"Radiology"},{"issue":"25","key":"BFbjc20158_CR29","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1200\/JCO.2012.46.1574","volume":"31","author":"O Metzger-Filho","year":"2013","unstructured":"Metzger-Filho O, Sun Z, Viale G, Price KN, Crivellari D, Snyder RD, Gelber RD, Castiglione-Gertsch M, Coates AS, Goldhirsch A, Cardoso F (2013) Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. J Clin Oncol 31 (25): 3083\u20133090.","journal-title":"J Clin Oncol"},{"issue":"9","key":"BFbjc20158_CR30","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00432-013-1478-1","volume":"139","author":"P Minicozzi","year":"2013","unstructured":"Minicozzi P, Bella F, Toss A, Giacomin A, Fusco M, Zarcone M, Tumino R, Falcini F, Cesaraccio R, Candela G, La Rosa F, Federico M, Sant M (2013) Relative and disease-free survival for breast cancer in relation to subtype: a population-based study. J Cancer Res Clin Oncol 139 (9): 1569\u20131577.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"BFbjc20158_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000089260","volume":"26","author":"R Molina","year":"2005","unstructured":"Molina R, Barak V, van Dalen A, Duffy MJ, Einarsson R, Gion M, Goike H, Lamerz R, Nap M, Soletormos G, Stieber P (2005) Tumor markers in breast cancer- European Group on Tumor Markers recommendations. Tumour Biol 26 (6): 281\u2013293.","journal-title":"Tumour Biol"},{"issue":"4A","key":"BFbjc20158_CR32","first-page":"2551","volume":"19","author":"R Molina","year":"1999","unstructured":"Molina R, Jo J, Filella X, Zanon G, Farrus B, Munoz M, Latre ML, Pahisa J, Velasco M, Fernandez P, Estape J, Ballesta AM (1999) C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. Anticancer Res 19 (4A): 2551\u20132555.","journal-title":"Anticancer Res"},{"issue":"1","key":"BFbjc20158_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF00690183","volume":"36","author":"R Molina","year":"1995","unstructured":"Molina R, Zanon G, Filella X, Moreno F, Jo J, Daniels M, Latre ML, Gimenez N, Pahisa J, Velasco M, Ballesta AM (1995) Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 36 (1): 41\u201348.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"BFbjc20158_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1258\/ar.2011.110245","volume":"53","author":"R Murakami","year":"2012","unstructured":"Murakami R, Kumita S, Yoshida T, Ishihara K, Kiriyama T, Hakozaki K, Yanagihara K, Iida S, Tsuchiya S (2012) FDG-PET\/CT in the diagnosis of recurrent breast cancer. Acta Radiol 53 (1): 12\u201316.","journal-title":"Acta Radiol"},{"issue":"10","key":"BFbjc20158_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopha.2003.09.004","volume":"57","author":"A Nicolini","year":"2003","unstructured":"Nicolini A, Carpi A, Michelassi C, Spinelli C, Conte M, Miccoli P, Fini M, Giardino R (2003) \"Tumour marker guided\" salvage treatment prolongs survival of breast cancer patients: final report of a 7-year study. Biomed Pharmacother 57 (10): 452\u2013459.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"BFbjc20158_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/bjc.1991.260","volume":"64","author":"A Nicolini","year":"1991","unstructured":"Nicolini A, Colombini C, Luciani L, Carpi A, Giuliani L (1991) Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. Br J Cancer 64 (1): 154\u2013158.","journal-title":"Br J Cancer"},{"issue":"7","key":"BFbjc20158_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/jnci\/djq029","volume":"102","author":"O Pagani","year":"2010","unstructured":"Pagani O, Senkus E, Wood W, Colleoni M, Cufer T, Kyriakides S, Costa A, Winer EP, Cardoso F (2010) International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst 102 (7): 456\u2013463.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"BFbjc20158_CR38","first-page":"74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA: a cancer journal for clinicians 55 (2): 74\u2013108.","journal-title":"CA: a cancer journal for clinicians"},{"issue":"6","key":"BFbjc20158_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/RLU.0b013e31805375e0","volume":"32","author":"E Piperkova","year":"2007","unstructured":"Piperkova E, Raphael B, Altinyay ME, Castellon I, Libes R, Sandella N, Heiba S, Abdel-Dayem H (2007) Impact of PET\/CT in comparison with same day contrast enhanced CT in breast cancer management. Clin Nucl Med 32 (6): 429\u2013434.","journal-title":"Clin Nucl Med"},{"issue":"11","key":"BFbjc20158_CR40","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/cncr.22292","volume":"107","author":"L Radan","year":"2006","unstructured":"Radan L, Ben-Haim S, Bar-Shalom R, Guralnik L, Israel O (2006) The role of FDG-PET\/CT in suspected recurrence of breast cancer. Cancer 107 (11): 2545\u20132551.","journal-title":"Cancer"},{"issue":"20","key":"BFbjc20158_CR41","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1001\/jama.271.20.1593","volume":"271","author":"M Rosselli Del Turco","year":"1994","unstructured":"Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V (1994) Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 271 (20): 1593\u20131597.","journal-title":"JAMA"},{"issue":"3","key":"BFbjc20158_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/172460089200700307","volume":"7","author":"A Ruibal Morell","year":"1992","unstructured":"Ruibal Morell A (1992) CEA serum levels in non-neoplastic disease. Int J Biol Markers 7 (3): 160\u2013166.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"BFbjc20158_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2014.0008","volume":"12","author":"DS Seah","year":"2014","unstructured":"Seah DS, Luis IV, Macrae E, Sohl J, Litsas G, Winer EP, Lin NU, Burstein HJ (2014) Use and duration of chemotherapy in patients with metastatic breast cancer according to tumor subtype and line of therapy. J Natl Compr Canc Netw 12 (1): 71\u201380.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"BFbjc20158_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000027745","volume":"62","author":"PM Som","year":"2000","unstructured":"Som PM, Curtin HD, Mancuso AA (2000) The new imaging-based classification for describing the location of lymph nodes in the neck with particular regard to cervical lymph nodes in relation to cancer of the larynx. ORL J Otorhinolaryngol Relat Spec 62 (4): 186\u2013198.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"20","key":"BFbjc20158_CR45","first-page":"35","volume":"147","author":"P Stieber","year":"2005","unstructured":"Stieber P, Heinemann V, Schalhorn A (2005) [Tumor markers\u2014how they should be applied]. MMW Fortschritte der Medizin 147 (20): 35 37-9.","journal-title":"MMW Fortschritte der Medizin"},{"issue":"1-2","key":"BFbjc20158_CR46","first-page":"15","volume":"49","author":"P Stieber","year":"2003","unstructured":"Stieber P, Molina R, Chan DW, Fritsche HA, Beyrau R, Bonfrer JM, Filella X, Gornet TG, Hoff T, Jager W, van Kamp GJ, Nagel D, Peisker K, Sokoll LJ, Troalen F, Untch M, Domke I (2003) Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients. Clin Lab 49 (1-2): 15\u201324.","journal-title":"Clin Lab"},{"issue":"2","key":"BFbjc20158_CR47","first-page":"113","volume":"46","author":"M Suarez","year":"2002","unstructured":"Suarez M, Perez-Castejon MJ, Jimenez A, Domper M, Ruiz G, Montz R, Carreras JL (2002) Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers. Q J Nucl Med 46 (2): 113\u2013121.","journal-title":"Q J Nucl Med"},{"issue":"3","key":"BFbjc20158_CR48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/BF02967510","volume":"8","author":"T Suzuma","year":"2001","unstructured":"Suzuma T, Sakurai T, Yoshimura G, Umemura T, Tamaki T, Naito Y (2001) A mathematical model of axillary lymph node involvement considering lymph node size in patients with breast cancer. Breast Cancer 8 (3): 206\u2013212.","journal-title":"Breast Cancer"},{"issue":"2","key":"BFbjc20158_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.breast.2004.10.003","volume":"14","author":"CR Tait","year":"2005","unstructured":"Tait CR, Waterworth A, Loncaster J, Horgan K, Dodwell D (2005) The oligometastatic state in breast cancer: hypothesis or reality. Breast 14 (2): 87\u201393.","journal-title":"Breast"},{"issue":"8","key":"BFbjc20158_CR50","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s003300050549","volume":"8","author":"D Vanel","year":"1998","unstructured":"Vanel D, Bittoun J, Tardivon A (1998) MRI of bone metastases. Eur Radiol 8 (8): 1345\u20131351.","journal-title":"Eur Radiol"},{"issue":"Suppl 1","key":"BFbjc20158_CR51","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med 50 (Suppl 1): 122S\u2013150S.","journal-title":"J Nucl Med"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc20158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc20158","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc20158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:31:57Z","timestamp":1684416717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc20158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFbjc20158"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2015.8","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]},"assertion":[{"value":"24 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}